Position in VCEL
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$11,107,951
+$3,151,539 QoQ
Shares Held
249,673
+0.9% QoQ
Ownership
0.488%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#46
of 317 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,857,842,341 across 105 Biotechnology names. VCEL ranks #35 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in VCEL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,107,951 | 249,673 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $7,956,412 | 247,324 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $8,708,477 | 241,835 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $7,678,868 | 244,006 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $10,627,075 | 249,755 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $12,054,271 | 270,154 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $14,437,595 | 262,932 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $10,641,000 | 251,858 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $15,768,588 | 343,692 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $21,353,585 | 410,488 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $9,066,910 | 254,617 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $8,758,507 | 261,292 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $10,412,074 | 277,138 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $8,559,035 | 291,918 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $7,855,351 | 298,229 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $6,911,650 | 297,916 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $7,572,532 | 300,736 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $13,279,347 | 347,445 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $14,251,240 | 362,627 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $19,888,098 | 407,543 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $22,258,529 | 423,972 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $19,850,403 | 357,343 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $617,013 | 19,981 | Shares | Defined | 2021-02-23 | |
| No filing history on record for this holder in this stock. | ||||||